Loading clinical trials...
Loading clinical trials...
Phase 2/3 Study of Intravenous Thrombolysis and Hypothermia for Acute Treatment of Ischemic Stroke
Conditions
Interventions
hypothermia and anti-shivering treatment
Group1: IV t-PA and normothermia
Locations
31
United States
University of Alabama Hospital
Birmingham, Alabama, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
University of California San Diego Health System
San Diego, California, United States
Scripps Mercy Medical Center
San Diego, California, United States
University of Colorado Hospital
Aurora, Colorado, United States
Start Date
June 1, 2010
Primary Completion Date
January 1, 2015
Completion Date
May 1, 2015
Last Updated
April 5, 2017
NCT06658197
NCT02879123
NCT05338697
NCT06075628
NCT06094478
NCT05487417
Lead Sponsor
University of California, San Diego
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions